[1] Kaye S B, Baker K, Bonshek R, et al. Human herpesviruses in the cornea[J]. Br J Ophthalmol, 2000, 84:563-571.
[2] Ding T T, Zhang Y B, Ren Z X, et al. EBV-associated hub genes as potential biomarkers for predicting the prognosis of nasophmTngeal carcinoma[J]. Viruses, 2023, 15(9):1915.
[3] Chakravorty S, Afzali B, Kazemian M. EBV-associated diseases: Current therapeutics and emerging technologies[J]. Front Immunol, 2022, 13:1059133.
[4] Widmer S, Tinguely, Megli F, et al. Epstein-Barr virus associated NK T-cell lymphoma with primary manifestation in the conjunctiva[J]. Klim Monbl Augenheikd, 2005, 222(3):255-257.
[5] Matoba A Y, Wilhelmus K R, Jones D B. Epstein-Barr viral stromal keratitis[J]. Ophthalmology, 1986, 93(6):746-751.
[6] Park G B, Kim D, Kim Y S, et al. The Epstein-Barr virus causes epithelial-mesenchymal transition in human corneal epithelial cells via Syk/src and Akt/Erk signaling pathways[J]. Invest Ophthalmol Vis Sci, 2014, 55(3):1770-1779.
[7] 张爱雪, 孙旭光, 王智群, 等. 疱疹病毒性角膜炎患者泪液病毒学检测及临床特征[J]. 眼科, 2015, 24(2):123-127.
[8] 李 莹. 单纯疱疹病毒性角膜炎的临床特点及诊疗思维[J]. 眼科, 2012, 21(3): 157-161.
[9] 王 欣, 徐建江, 乐琦骅, 等. 更昔洛韦胶囊治疗单纯疱疹病毒性角膜炎的临床观察[J]. 中华眼科杂志, 2010, 46(11): 994-1001.
[10] 祝伊莎. 盐酸伐昔洛韦片与更昔洛韦注射液治疗小儿EB病毒感染的效果比较[J]. 中国社区医生, 2025, 41(3):27-29.
[11] Rao S N. Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topicalcyclosporine 0. 05%[J]. Am J Ophthalmol, 2006, 141(4): 771-772.
[12] Sheppard J D, Wertheimer M L, Scoper S V. Modalities to decrease stromal herpes simplex keratitis reactivation rates[J]. Arch Ophthalmol, 2009, 127(7): 852-856.
[13] Long Jianfeng, Li Haoyu, Zhang Liwei, et al. A new technique of sterile polyethylene instrument cover as temporary corneal patch to reconstruct anterior chamber in penetrating keratoplasty combined with intraocular surgery[J]. Retina, 2024, 45(5):1016-1021.